Kalehua Capital Management LLC
Kalehua Capital Management LLC reported 23 holdings worth US$140M as of Jun 30, 2026 (Form 13F)
As of Jun 30, 2026 · Filed Aug 14, 2026
Kalehua Capital Management LLC reported 23 holdings worth US$140M as of Jun 30, 2026. Largest: Veradermics, Incorporated, X4 Pharmaceuticals, Inc. and Surrozen, Inc. Filed Aug 14, 2026 (Form 13F).
- Holdings
- 23
- Value as reported
- US$140M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|---|---|---|
| Veradermics, Incorporated | 291K | US$35.8M | 11.4% |
| X4 Pharmaceuticals, Inc. | 7.45M | US$34.8M | 11.1% |
| Surrozen, Inc. | 770K | US$20M | 6.4% |
| Aclaris Therapeutics, Inc. | 3.66M | US$19.4M | 6.2% |
| Sionna Therapeutics, Inc. | 394K | US$17.3M | 5.5% |
| Inhibikase Therapeutics, Inc. | 7.64M | US$15.5M | 4.9% |
| Karyopharm Therapeutics Inc. | 1.37M | US$13.4M | 4.3% |
| Septerna, Inc. | 389K | US$13M | 4.2% |
| Cyclerion Therapeutics, Inc. | 3.3M | US$11.2M | 3.6% |
| Leonabio, Inc. | 787K | US$7.24M | 2.3% |
| Damora Therapeutics, Inc. | 278K | US$7.23M | 2.3% |
| Korro Bio, Inc. | 405K | US$5.34M | 1.7% |
| Tyra Biosciences, Inc. | 149K | US$4.76M | 1.5% |
| Nuvectis Pharma, Inc. | 200K | US$3.68M | 1.2% |
| Gossamer Bio, Inc. | 22.3M | US$3.67M | 1.2% |
| Milestone Pharmaceuticals Inc. | 2.54M | US$3.4M | 1.1% |
| Atyr Pharma, Inc. | 3.58M | US$2.13M | 0.68% |
| Instil Bio, Inc. | 199K | US$1.53M | 0.49% |
| Tscan Therapeutics, Inc. | 910K | US$892K | 0.28% |
| Diamedica Therapeutics Inc. | 0 | US$0 | 0.00% |
| Kalaris Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Loop Industries, Inc. | 0 | US$0 | 0.00% |
| Oruka Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Pepgen Inc. | 0 | US$0 | 0.00% |
| Relay Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Tenaya Therapeutics, Inc. | 0 | US$0 | 0.00% |